My research focuses on the rational design of stimuli-responsive metal-based anticancer complexes with enhanced therapeutic selectivity and efficacy. This includes the development of photodynamic therapeutic agents, small-molecule inhibitors such as tyrosine kinase and epidermal growth factor receptor inhibitors, and targeted drug delivery systems aimed at improving tumor specificity and reducing systemic toxicity. This work integrates principles of chemistry, biology, and medicinal science to advance innovative and translational cancer therapies.